Evidence map›Paper›PMID 29288400›Full record

ArticleClinical oral investigations2018

Anti-inflammatory and antiresorptive effects of Calendula officinalis on inflammatory bone loss in rats.

Joanna Trycia M Alexandre, Luzia Hermínia Teixeira Sousa, Mario Roberto Pontes Lisboa, Flávia A C Furlaneto, Danielle Rocha do Val, Mirna Marques, Hellíada C Vasconcelos, Iracema Matos de Melo, Renata Leitão, Gerly Anne Castro Brito and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical oral investigations, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Effects of 3% binahong (F1000Research · 2021
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Joanna Trycia M AlexandrePost-Graduation Program in Health Science, Federal University of Ceará, Sobral, CE, Brazil.
Luzia Hermínia Teixeira SousaPost-Graduation Program RENORBIO, Federal University of Ceará, Sobral, CE, Brazil.
Mario Roberto Pontes LisboaPost-Graduation Program in Morphofunctional Science, Federal University of Ceará, Fortaleza, CE, Brazil.
Flávia A C FurlanetoDepartment of Surgery and Bucco-Maxilofacial Traumatology and Periodontology, Ribeirão Preto School of Dentistry, University of São Paulo, Ribeirão Preto, SP, Brazil.
Danielle Rocha do ValRenorbio Post-Graduation Program, Federal University of Pernambuco, Recife, PE, Brazil.
Mirna MarquesMedical School, Federal University of Ceará, Sobral, CE, Brazil.
Hellíada C VasconcelosDental School, Federal University of Ceará, Sobral, CE, Brazil.
Iracema Matos de MeloDental School, Federal University of Ceará, Sobral, CE, Brazil.
Renata LeitãoDepartment of Morphology, Medical School, Federal University of Ceará, Fortaleza, CE, Brazil.
Gerly Anne Castro BritoDepartment of Morphology, Medical School, Federal University of Ceará, Fortaleza, CE, Brazil.
Paula GoesDepartment of Pathology and Legal Medicine, Faculty of Medicine, Federal University of Ceará, Rua Monsenhor Furtado, s/n 60441-750. Rodolfo Teófilo, Fortaleza, CE, Brazil. paulagpinheiro@yahoo.com.br.
Universidade Federal do Ceará · BRUniversidade de São Paulo · BRUniversidade Federal de Pernambuco · BR

Funding

CNPq 480481/2013-0FUNCAP PJP-0072-00092.01.00/12
6 · The paper itself

Abstract

objectiveThe aim of this work was to evaluate the anti-inflammatory and antiresorptive effects of Calendula officinalis (CLO) on alveolar bone loss (ABL) in rats. MATERIAL AND

methodsMale Wistar rats were subjected to ABL by ligature with nylon thread around the second upper left molar. The contralateral hemimaxillae were used as control. Rats received saline solution (SAL) or CLO (10, 30, or 90 mg/kg) 30 min before ligature and daily until the 11th day. The maxillae were removed and prepared for macroscopic, radiographic, micro-tomographic, histopathologic, histometric analysis, and immunohistochemical localization of receptor activator of nuclear factor kappa-B ligand (RANKL) and osteoprotegerin (OPG). The gingival tissues were used to quantify the myeloperoxidase (MPO) activity, tumor necrosis factor-alpha (TNF-α), and interleukin-1β (IL-1β) concentrations by ELISA. Blood samples were collected for leukogram and to evaluate the bone-specific alkaline phosphatase (BALP) activity and serum levels of aspartate and alanine transaminases (AST/ALT).

resultsThe bone loss induced by 11 days of ligature induced bone loss, reduced levels of BALP, leukocyte infiltration, increased MPO activity, gingival concentrations of TNF-α and IL-1β, and RANKL while reduced OPG immunoexpressions in the periodontal tissue and leukocytosis. Of the CLO, 90 mg/kg reduced bone loss, neutrophilia, the levels of pro-inflammatory mediators, and RANKL expression, while it increased OPG immunopositive cells and BALP serum levels, when compared to SAL. CLO did not affect either kidney or liver function, indicated by serum AST/ALT levels.

conclusionThe present data suggests that CLO reduced inflammatory bone resorption in experimental periodontitis, which may be mediated by its anti-inflammatory properties and its effects on bone metabolism. CLINICAL RELEVANCE: CLO can be a potential therapeutical adjuvant in the treatment of periodontitis.

Indexed as

CalendulaAlanine TransaminaseAlkaline PhosphataseAlveolar Bone LossAnimalsAspartate AminotransferasesBiomarkersDisease Models, AnimalEnzyme-Linked Immunosorbent AssayInterleukin-1betaLigationMaleMaxillaMolarOsteoprotegerinPlant ExtractsAlanine TransaminaseAlkaline PhosphataseAspartate AminotransferasesBiomarkersInterleukin-1betaOsteoprotegerinPlant ExtractsRANK LigandTumor Necrosis Factor-alphaBone lossCalendula officinalisInflammationPeriodontitisRats

Identifiers

PMID29288400
OpenAlexW2781167675

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.